These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 17239838

  • 21. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 22. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
    Pradhan V, Mahant G, Rajadhyaksha A, Surve P, Rajendran V, Patwardhan M, Nadkarni A, Dighe S, Ghosh K.
    Rheumatol Int; 2013 Jun; 33(6):1533-9. PubMed ID: 23255139
    [Abstract] [Full Text] [Related]

  • 23. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E, Kralikova P.
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [Abstract] [Full Text] [Related]

  • 24. Clearance of apoptotic cells in human SLE.
    Gaipl US, Kuhn A, Sheriff A, Munoz LE, Franz S, Voll RE, Kalden JR, Herrmann M.
    Curr Dir Autoimmun; 2006 May; 9():173-87. PubMed ID: 16394661
    [Abstract] [Full Text] [Related]

  • 25. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus.
    Seelen MA, Trouw LA, van der Hoorn JW, Fallaux-van den Houten FC, Huizinga TW, Daha MR, Roos A.
    Clin Exp Immunol; 2003 Nov; 134(2):335-43. PubMed ID: 14616796
    [Abstract] [Full Text] [Related]

  • 26. Binding of circulating SLE autoantibodies to oxygen free radical damaged chromatin.
    Mansoor F, Ali A, Ali R.
    Autoimmunity; 2005 Sep; 38(6):431-8. PubMed ID: 16278148
    [Abstract] [Full Text] [Related]

  • 27. Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases.
    Bell SA, Faust H, Schmid A, Meurer M.
    Clin Exp Immunol; 1998 Sep; 113(3):327-32. PubMed ID: 9737658
    [Abstract] [Full Text] [Related]

  • 28. Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation.
    Massardo L, Metz C, Pardo E, Mezzano V, Babul M, Jarpa E, Guzmán AM, André S, Kaltner H, Gabius HJ, Jacobelli S, González A, Soza A.
    Lupus; 2009 May; 18(6):539-46. PubMed ID: 19395456
    [Abstract] [Full Text] [Related]

  • 29. Relevance of anti-C1q autoantibodies to lupus nephritis.
    Tsirogianni A, Pipi E, Soufleros K.
    Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
    [Abstract] [Full Text] [Related]

  • 30. C-reactive protein: ligands, receptors and role in inflammation.
    Marnell L, Mold C, Du Clos TW.
    Clin Immunol; 2005 Nov; 117(2):104-11. PubMed ID: 16214080
    [Abstract] [Full Text] [Related]

  • 31. Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity.
    Kravitz MS, Pitashny M, Shoenfeld Y.
    J Clin Immunol; 2005 Nov; 25(6):582-91. PubMed ID: 16380821
    [Abstract] [Full Text] [Related]

  • 32. C-reactive protein, anti-C-reactive protein antibodies and clinical atherosclerosis.
    Rosenau BJ, Costenbader KH, Schur PH.
    Vasc Med; 2008 Feb; 13(1):25-8. PubMed ID: 18372435
    [Abstract] [Full Text] [Related]

  • 33. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein.
    Yang XW, Tan Y, Yu F, Zhao MH.
    Hum Immunol; 2012 Feb; 73(2):156-63. PubMed ID: 22192784
    [Abstract] [Full Text] [Related]

  • 34. Autoimmunity to protective molecules: is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic diseases?
    Kravitz MS, Shoenfeld Y.
    Nat Clin Pract Rheumatol; 2006 Sep; 2(9):481-90. PubMed ID: 16951703
    [Abstract] [Full Text] [Related]

  • 35. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Rosenau BJ, Schur PH.
    J Rheumatol; 2009 Apr; 36(4):753-6. PubMed ID: 19273453
    [Abstract] [Full Text] [Related]

  • 36. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein.
    Rodriguez W, Mold C, Kataranovski M, Hutt J, Marnell LL, Du Clos TW.
    Arthritis Rheum; 2005 Feb; 52(2):642-50. PubMed ID: 15692982
    [Abstract] [Full Text] [Related]

  • 37. Autoantibodies to opsonins of apoptotic cells in systemic lupus erythematosus.
    Limburg PC, Bijl M.
    Ann Rheum Dis; 2005 Dec; 64(12):1669-70. PubMed ID: 16284341
    [No Abstract] [Full Text] [Related]

  • 38. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J, Wener MH, Mannik M.
    J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
    [Abstract] [Full Text] [Related]

  • 39. Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players.
    Kruse K, Janko C, Urbonaviciute V, Mierke CT, Winkler TH, Voll RE, Schett G, Muñoz LE, Herrmann M.
    Apoptosis; 2010 Sep; 15(9):1098-113. PubMed ID: 20198437
    [Abstract] [Full Text] [Related]

  • 40. Lupus nephritis sera contain autoantibodies that recognize epitopes within the globular fragment of C1q.
    Deliyska B, Tsacheva I, Radanova M, Stoianova V, Tchorbadjieva M, Dobreva N.
    Med Pregl; 2007 Sep; 60 Suppl 2():25-7. PubMed ID: 18928152
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.